Basics Gyre Therapeutics, Inc. IPO Date: August 21, 2015 Sector: Healthcare Industry: Biotech Market Cap: $698.46M Activated in VL: True Average Daily Range Avg Daily Range: $0.29 | 3.85% Avg Daily Range (30 D): $0.26 | 3.43% Avg Daily Range (90 D): $0.33 | 3.86% Institutional Daily Volume Avg Daily Volume: .43M Avg Daily Volume (30 D): .07M Avg Daily Volume (90 D): .15M Trade Size Avg Trade Size (Sh.): 243 Avg Trade Size (Sh.) (30 D): 60 Avg Trade Size (Sh.) (90 D): 69 Institutional Trades Total Inst.Trades: 120 Avg Inst. Trade: $1.59M Avg Inst. Trade (30 D): $1.63M Avg Inst. Trade (90 D): $1.44M Avg Inst. Trade Volume: .46M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.83M Avg Closing Trade (30 D): $3.74M Avg Closing Trade (90 D): $3.74M Avg Closing Volume: 584.83K     News Aug 22, 2025 @ 11:00 AM Gyre Therapeutics Announces the Appointment of Dan... Source: Gyre Therapeutics Jun 10, 2025 @ 11:00 AM Gyre Therapeutics Announces First Dosing in Phase ... Source: N/A May 23, 2025 @ 12:57 AM Gyre Therapeutics Announces Pricing of $20.0 Milli... Source: N/A Jun 18, 2024 @ 8:05 PM Gyre Therapeutics Announces Publication in Journal... Source: Gyre Therapeutics, Inc. May 28, 2024 @ 8:05 PM Gyre Therapeutics Announces Expected Addition to t... Source: Gyre Therapeutics, Inc. Financials   TTM Q1 2025 Q4 2024 Basic EPS $ $.03 $ Diluted EPS $ $ $ Revenue $ 26.77M $ 22.06M $ 27.87M Gross Profit $ 25.62M $ 21.16M $ 26.7M Net Income / Loss $ 2.71M $ 3.73M $ .57M Operating Income / Loss $ 2.17M $ 2.27M $ .6M Cost of Revenue $ 1.15M $ .89M $ 1.18M Net Cash Flow $ 21.4M $ 3.18M $ -3.8M PE Ratio     Splits Jan 13, 2023:   2:1 Feb 13, 2017:   1:15 Aug 21, 2015:   1:7